Skip to main
NEOG

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation exhibits a strong position in the food and animal safety markets, supported by its diverse portfolio of diagnostic and safety products aimed at preventing contamination and foodborne illnesses. The company's recent acquisition has enhanced its market position, indicating a strategic approach to growth through both internal development and acquisitions. Despite facing risks such as competition and supply chain sensitivities, Neogen's focus on innovation and safety solutions contributes to a fundamentally positive outlook for its financial performance.

Bears say

Neogen Corporation's recent financial reports indicate declining revenue growth, which raises concerns about its ability to maintain market share in the competitive food and animal safety sectors. Additionally, the company has faced increasing operational costs, which have negatively impacted profit margins and overall profitability. Furthermore, challenges in product innovation and a lack of diversification in its product offerings could hinder Neogen's long-term growth potential.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Mar 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.